Skip to main content
. 2025 Nov 28;16:2343. doi: 10.1007/s12672-025-04188-2

Table 3.

Represent The clinical trial of CRISPR-CAS9. (https://clinicaltrials.gov). The table represent different clinical trials of phase 1 in various cancer using CRISPR-CAS9 system

Clinical Trial CANCER TYPE Related CRISPR Method
Phase 1 Refractory cancers Delete two genes that encode TCR and a gene encoding PD-1
Advanced NSCLC Edite PD-1 on T cells
Mesothelin-positive solid tumors PD-L1 possible target for knockout
Refractory solid cancers Knockout two (TCR) gene